Tag Archives: trastuzumab

FDA Approves First Targeted Therapy to Treat HER2-Low Breast Cancer

On August 05, 2022, the U.S. FDA approved Enhertu (T-DXd) or (trastuzumab deruxtecan), an IV infusion to treat patients with […]

ikrisuser
August 9, 2022